WST — WEST PHARMACEUTICAL SVSC INC

Ownership history in MATHER GROUP, LLC.  ·  12 quarters on record

This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in WEST PHARMACEUTICAL SVSC INC (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q3)
Avg. % of fund
0.01%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 686 -198 -22.4% 0.00% $180K $261.88
2025 Q1 REDUCED 884 -225 -20.3% 0.00% $198K $223.09
2024 Q4 REDUCED 1,109 -357 -24.4% 0.00% $363K $326.20
2024 Q3 ADDED 1,466 +143 +10.8% 0.01% $440K $298.72
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    WST price (monthly, adj. close)

Other funds also holding WST

As of 2025 Q4 — sorted by position size

Alpine Peaks Capital, LP 3Y 6.94% Seilern Investment Management Ltd 5.94% McCollum Christoferson Group LLC 3Y 7Y 3.27% Longview Partners (Guernsey) LTD 3Y 7Y 3.25% GENERATION INVESTMENT MANAGEMENT LLP 3Y 7Y 2.98% AMI ASSET MANAGEMENT CORP 3Y 7Y 2.48% Findlay Park Partners LLP 3Y 7Y 2.34% GRACE & WHITE INC /NY 3Y 7Y 2.14% William Allan Corp 3Y 2.05% STEADFAST CAPITAL MANAGEMENT LP 3Y 7Y 2.03%
← Back to MATHER GROUP, LLC. Holdings